Neurofibromatosis type 1 associated with pheochromocytoma: A case report and a review of the literature

Journal of Endocrinological Investigation

Volumn 30, Issue 1, 2007, Pages 59-64

  Erem, C ^a   Onder Ersoz H ^a   Ukinc K ^a   Hacihasanoglu, A ^a   Alhan, E ^a   Cobanoglu U ^a   Kocak M ^a   Erdol H ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Hypertension; Pheochromocytoma; Type I neurofibromatosis

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; PHENOXYBENZAMINE; PROPRANOLOL;

ABDOMEN; ADRENAL GLAND; ADRENAL TUMOR; ADRENALECTOMY; ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CAFE AU LAIT SPOT; CASE REPORT; CATECHOLAMINE URINE LEVEL; ECHOGRAPHY; HAMARTOMA; HEADACHE; HEART PALPITATION; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INCIDENTAL FINDING; IRIS DISEASE; LENTIGO; LIMB; MALE; MEDICAL LITERATURE; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; SCINTISCANNING; SKINFOLD; SOLID TUMOR; SWEATING; TRUNK; TUMOR VOLUME; TURKEY (REPUBLIC);

EID: 33947503649     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347397     Document Type: Article

References (39)

1. Lenders JWM, Eisen G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005, 366: 665-75.
2. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Phaeochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 2003, 95: 1196-204.
3. Erem C, Kocak M, Onder Ersoz H, Ersoz S, Yucel V. Epinephrine-secreting cystic pheochromocytoma presenting with incidental adrenal mass: a case report and a review of the literature. Endocrine 2005, 28: 225-30.
4. Hernandez FC, Sanchez M, Alvarez A, et al. A five-year report on experience in the detection of pheochromocytoma. Clin Biochem 2001, 33: 649-55.
5. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Eng J Med 2002, 346: 1459-66.
6. Maher ER, Eng C. The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet 2002, 11: 2347-54.
7. Goldberg NS, Roenigk RK. Neurofibromatosis, tuberous sclerosis, and other neurocutaneous disorders. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU eds. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia: WB Saunders. 1996, 1729-41.
8. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of phaeochromocytoma. Ann Intern Med 2001, 134: 315-29.
9. Gutmann DH. The neurofibromatosis: when less in more. Hum Mol Genet 2001, 10: 747-55.
10. Suzuki S. Ueber Zwei Tumoren aus Nebennierenmarkgewebe. Berlin Clin Wchnschr 1910, 47: 1623.
11. Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997, 79:2125-31.
12. Walther MM, Herring J, Enquist E, Keiser HR. Linehan WM. Von Recklinghausen's disease and pheochromocytomas. J Urol 1999, 162: 1582-6.
13. Heim RA, Kam-Morgan LN, Binnie CG, et al. Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 1995, 4: 975-81.
14. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation of multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997, 278: 51-7.
15. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999, 89: 1-6.
16. Jenne DE, Tinschert S, Reimann H, et al. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q.11.2 micro-deletions. Am J Hum Genet 1989, 26: 704-11.
17. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in South East Wales. I. Prevalence, fitness, mutation rate, and effect of parenteral trasmission on severity. J Med Genet 1989, 26: 704-11.
18. Hirsch NP, Murphy A, Radcliffe JJ. Neurofibromatosis: clinical presentations and anaesthetic implications. Br J Anaesth 2001, 86:555-64.
19. Huson SM, Harper PS, Compston DAS. von Recklinghausen's neurofibromatosis: a clinical and population study in South East Wales. Brain 1988, 111: 1355-81.
20. Huson S, Jones D, Beck L. Ophthalmic manifestations of neurofibromatosis. Br J Ophthalmol 1987, 71:235-8
21. Opocher G, Conton P, Schiavi F, Macino B, Mantero F. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1. Fam Cancer 2005, 4:13-6.
22. Rabii R. Fekak H, Moufid K, Bennani S, El Mrini M, Benjelloun S. Phéochromocytoma et maladie de von Recklinghausen. Ann Urol 2002, 36: 254-7.
23. Al-Wahhabi B. Parathyroid adenoma and bilateral pheochromocytoma in a patient with neurofibromatosis. Ann Saudi Med 2005, 25: 255-7.
24. Ogawa T, Mitsukawa T, Ishikawa T, Tamura K. Familial pheochromocytoma associated with von Recklinghausen's disease. Intern Med 1994, 33 110-4.
25. Goldstein RE, O'Neill JA Jr, Holcomp GW 3rd, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 1999, 229:755-64.
26. Lynch JD, Sheps SG, Bernatz PE, ReMine WH, Harrison EG Jr. Neurofibromatosis and hypertension due to pheochromocytoma or renal artery stenosis. Minnesota Med 1972, 55: 25-31.
27. Kremen AF, Hill E, Kremen AJ. Pheochromocytoma, renal artery stenosis, and lymphocytic lymphoma associated with von Recklinghausen's neurofibromatosis. Case report and literature review. Minnesota Med 1985, 68:99-101.
28. Blum MD, Bahnson RR, Carter MF. Urologic manifestations of von Recklinghausen's neurofibromatosis. Urology 1985, 26 209-17.
29. Akuzawa N, Nakamura T, Tanaka A, et al. Transient hypertension due to adrenal hemorrhage in a patient with von Recklinghausen's disease. Intern Med 1997, 36:289-92.
30. Bourke E, Gatenby PBB. Renal artery dysplasia with hypertension in neurofibromatosis. Br Med J 1971, 18: 681-2.
31. Sakane N, Shirakata S, Jin MB, Torii T, Yoshida T. von Recklinghausen's disease with hyperthyroidism. Intern Med 1997, 36: 938.
32. Sartori P, Symons JC, Taylor NF, Grant DB. Adrenal cortical adenoma in a 13-year-old girl with neurofibromatosis. Case report and review of the literature. Acta Paediatr Scand 1989, 78: 476-8.
33. Friedman JM, Arbiser J, Epstein JA, et al. Cardiovascular disease in neurofibromatosis type 1: report of the NF1 Cardiovascular Task Force. Genet Med 2002, 4: 105-11.
34. Kalff V, Shapiro B, Lloyd R, Sisson JC, Holland K, Nakajo M, Beierwaltes WH. The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med 1982, 142: 2092-8.
35. Walz MK, Peitgen K, Neumann HP, Janssen OE, Philipp T, Mann K. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 2002, 26: 1005-12.
36. Jaroszewski DE, Tessier DJ, Schlinkert RT, et al. Laparoscopic adrenalectomy for pheochromocytoma. Mayo Clin Proc 2003, 78: 1501-4.
37. Brauckhoff M, Gimm O, Brauckhoff K, Dralle H. Repeat adrenocortical-sparing adrenalectomy for recurrent hereditary pheochromocytoma. Surg Today 2004, 34: 251-5.
38. Neumann HP, Bender BU, Reincke M, Eggstein S, Lauben-berger J, Kirste, G. Adrenal-sparing surgery for phaeochromocytoma. Br J Surg 1999, 86:94-7.
39. Favier J, Briere JJ, Strompl L, et al. Hereditary paraganglioma/ pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res 2005, 63: 171-9.